GSK's Respiratory Syncytial Virus Older Adult Vaccine Candidate Gets Positive CHMP Opinion
27/4 09:02
(RTTNews) - GSK plc (GSK, GSK.L) said that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion by consensus recommending approval of GSK's respiratory syncytial virus or RSV vaccine candidate for the prevention of...